[Neuroleptic malignant syndrome].
Bryois
C
C
Services Hospitalo-ambulatoires A, Département Universitaire de Psychiatrie Adulte DUPA, Lausanne.
Bondolfi
G
G
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D003987:Dibenzothiazepines / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000628:therapy; D011595:Psychomotor Agitation; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012307:Risk Factors
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D008728:Methotrimeprazine; D006220:Haloperidol; C084602:clothiapine
Le syndrome malin des neuroleptiques.